Vistin Pharma ASA: Second quarter and first half 2022 financial results
August 19, 2022 01:50 ET
|
Vistin Pharma ASA
Oslo, Norway, 19th of August 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the second quarter 2022 Revenue in second quarter ended at MNOK 69...
Vistin Pharma ASA: Invitation to Q2 2022 conference call
August 11, 2022 07:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 11 August 2022 Vistin Pharma ASA will release its second quarter and YTD 2022 results on Friday 19th of August 2022. Vistin Pharma will host a conference call for all shareholders...
Vistin Pharma ASA: Minutes from the annual general meeting 2022
May 19, 2022 05:50 ET
|
Vistin Pharma ASA
Oslo, Norway, 19 May 2022 Vistin Pharma ASA (OSE: VISTIN), please find attached the minutes from the annual general meeting held on 19 May 2022. All matters were resolved as proposed in the call for...
Vistin Pharma ASA: Notice of Annual General Meeting
April 28, 2022 07:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 28 April 2020 Vistin Pharma ASA (OSE: VISTIN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 19 May at 10:00 CEST. A physical...
Vistin Pharma ASA: Annual Report for 2021
April 27, 2022 07:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 27 April 2022 Please find attached the Annual Report for 2021 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full...
Vistin Pharma ASA: First quarter 2022 financial results
April 27, 2022 01:45 ET
|
Vistin Pharma ASA
Oslo, Norway, 27th of April 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the first quarter 2022 Revenue in first quarter ended at MNOK 33 compared...
Vistin Pharma ASA: Invitation to Q1 2022 conference call
April 20, 2022 07:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 20 April 2022 Vistin Pharma ASA will release its first quarter 2022 results on Wednesday 27th of April 2022. Vistin Pharma will host a conference call for all shareholders and...
Vistin Pharma ASA: Fourth quarter 2021 financial results
February 17, 2022 01:40 ET
|
Vistin Pharma ASA
Oslo, Norway, 17th of February 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the fourth quarter 2021 Revenue in fourth quarter ended at MNOK 78...
New interim CEO
February 16, 2022 09:45 ET
|
Vistin Pharma ASA
CEO Kjell-Erik Nordby is currently on sick-leave, and the Board in Vistin Pharma, with effect from today, has appointed Magnus Tolleshaug as interim CEO. Magnus Tolleshaug has been employed in Vistin...
Vistin Pharma ASA: Invitation to Q4 2021 conference call
February 08, 2022 08:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 8 February 2022 Vistin Pharma ASA will release its fourth quarter 2021 results on Thursday 17th of February 2022. Vistin Pharma will host a conference call for all shareholders and...